A promising approach to control Staphylococcus aureus bacterial colonization in people – using a probiotic instead of antibiotics – was safe and highly effective in a Phase 2 clinical trial. The new study, reported in The Lancet Microbe, found that the probiotic Bacillus subtilis markedly reduced S. aureus colonization in trial participants without harming the gut microbiota, which includes bacteria that can benefit people. The research was conducted by researchers at the National Institutes of Health led by Michael Otto, Ph.D., an NIH senior investigator at the National Institute of Allergy and Infectious Diseases (NIAID).
Help a Friend
Search the Site
- The Grown Man’s Guide to Making and Keeping Friends | SELF September 22, 2023
- If anxiety is in my brain, why is my heart pounding? A psychiatrist explains the neuroscience and physiology of fear September 14, 2023
- ‘Everything you’ve been told is a lie!’ Inside the wellness-to-fascism pipeline August 6, 2023
- NIMH » NIMH announces that Lisa Bowleg, Ph.D., M.A., has been selected as the 2023 James S. Jackson Memorial Award winner August 2, 2023
- Keeping a Clean Mediterranean diet? Would you like to? If so, the NIH needs you. July 29, 2023